Literature DB >> 33684118

Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.

Nneka M Chika-Igwenyi1, Rebecca E Harrison2, Christina Psarra3, Julita Gil-Cuesta3, Maria Gulamhusein3, Emeka O Onwe4, Robinson C Onoh5, Uche S Unigwe1,6, Nnennaya A Ajayi1, Ugochukwu U Nnadozie7, Chiedozie K Ojide8,9, Damian U Nwidi1, Obumneme Ezeanosike4, Emeka Sampson10, Azuka S Adeke11, Collins N Ugwu1, Uchenna Anebonam12, Jacques K Tshiang13, Jacob Maikere13, Anthony Reid3.   

Abstract

Lassa fever (LF) is an acute viral haemorrhagic illness with various non-specific clinical manifestations. Neurological symptoms are rare at the early stage of the disease, but may be seen in late stages, in severely ill patients.The aim of this study was to describe the epidemiological evolution, socio-demographic profiles, clinical characteristics, and outcomes of patients seen during two Lassa fever outbreaks in Ebonyi State, between December 2017 and December 2018. Routinely collected clinical data from all patients admitted to the Virology Centre of the hospital during the period were analysed retrospectively. Out of a total of 83 cases, 70(84.3%) were RT-PCR confirmed while 13 (15.7%) were probable cases. Sixty-nine (83.1%) patients were seen in outbreak 1 of whom 53.6% were urban residents, while 19%, 15%, and 10% were farmers, students and health workers respectively. There were 14 (16.8%) patients, seen in second outbreak with 92.9% rural residents. There were differences in clinical symptoms, signs and laboratory findings between the two outbreaks. The case fatality rates were 29.9% in outbreak 1 and 85.7% for outbreak 2. Neurological features and abnormal laboratory test results were associated with higher mortality rate, seen in outbreak 2. This study revealed significant differences between the two outbreaks. Of particular concern was the higher case fatality during the outbreak 2 which may be from a more virulent strain of the Lassa virus. This has important public health implications and further molecular studies are needed to better define its characteristics.

Entities:  

Mesh:

Year:  2021        PMID: 33684118      PMCID: PMC7984835          DOI: 10.1371/journal.pntd.0009169

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  32 in total

Review 1.  Lassa virus.

Authors:  Stephan Günther; Oliver Lenz
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

2.  Lassa fever encephalopathy: clinical and laboratory findings.

Authors:  D Cummins; D Bennett; S P Fisher-Hoch; B Farrar; S J Machin; J B McCormick
Journal:  J Trop Med Hyg       Date:  1992-06

3.  Annual Incidence of Lassa Virus Infection in Southern Mali.

Authors:  David Safronetz; Nafomon Sogoba; Sory Ibrahim Diawara; Sidy Bane; Kyle Rosenke; Ousmane Maiga; Matt Boisen; Robert F Garry; Luis M Branco; L Robbin Lindsay; Sékou F Traoré; Heinz Feldmann; Seydou Doumbia
Journal:  Am J Trop Med Hyg       Date:  2017-01-16       Impact factor: 2.345

4.  Clinical, epidemiologic, and therapeutic aspects of Lassa fever.

Authors:  J B McCormick
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Genetic diversity among Lassa virus strains.

Authors:  M D Bowen; P E Rollin; T G Ksiazek; H L Hustad; D G Bausch; A H Demby; M D Bajani; C J Peters; S T Nichol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).

Authors:  Nnennaya A Ajayi; Chinedu G Nwigwe; Ben N Azuogu; Benson N Onyire; Elizabeth U Nwonwu; Lawrence U Ogbonnaya; Francis I Onwe; Tobin Ekaete; Stephan Günther; Kingsley N Ukwaja
Journal:  Int J Infect Dis       Date:  2013-07-17       Impact factor: 3.623

7.  Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.

Authors:  S P Fisher-Hoch; O Tomori; A Nasidi; G I Perez-Oronoz; Y Fakile; L Hutwagner; J B McCormick
Journal:  BMJ       Date:  1995-09-30

8.  Lassa Fever in Pregnancy: Report of 2 Cases Seen at the University College Hospital, Ibadan.

Authors:  O O Bello; O R Akinajo; K H Odubamowo; T A O Oluwasola
Journal:  Case Rep Obstet Gynecol       Date:  2016-03-09

9.  Increase in Lassa Fever Cases in Nigeria, January-March 2018.

Authors:  Elsie A Ilori; Christina Frank; Chioma C Dan-Nwafor; Oladipupo Ipadeola; Amrei Krings; Winifred Ukponu; Oboma E Womi-Eteng; Ayodele Adeyemo; Samuel K Mutbam; Emmanuel O Musa; Clement L P Lasuba; Wondimagegnehu Alemu; Sylvanus Okogbenin; Ephraim Ogbaini; Uche Unigwe; Emeka Ogah; Robinson Onoh; Chukwuyem Abejegah; Olufemi Ayodeji; Chikwe Ihekweazu
Journal:  Emerg Infect Dis       Date:  2019-05-17       Impact factor: 6.883

10.  Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.

Authors:  Katherine J Siddle; Philomena Eromon; Kayla G Barnes; Samar Mehta; Judith U Oguzie; Ikponmwosa Odia; Stephen F Schaffner; Sarah M Winnicki; Rickey R Shah; James Qu; Shirlee Wohl; Patrick Brehio; Christopher Iruolagbe; John Aiyepada; Eghosa Uyigue; Patience Akhilomen; Grace Okonofua; Simon Ye; Tolulope Kayode; Fehintola Ajogbasile; Jessica Uwanibe; Amy Gaye; Mambu Momoh; Bridget Chak; Dylan Kotliar; Amber Carter; Adrianne Gladden-Young; Catherine A Freije; Omigie Omoregie; Blessing Osiemi; Ekene B Muoebonam; Michael Airende; Rachael Enigbe; Benevolence Ebo; Iguosadolo Nosamiefan; Paul Oluniyi; Mahan Nekoui; Ephraim Ogbaini-Emovon; Robert F Garry; Kristian G Andersen; Daniel J Park; Nathan L Yozwiak; George Akpede; Chikwe Ihekweazu; Oyewale Tomori; Sylvanus Okogbenin; Onikepe A Folarin; Peter O Okokhere; Bronwyn L MacInnis; Pardis C Sabeti; Christian T Happi
Journal:  N Engl J Med       Date:  2018-10-17       Impact factor: 91.245

View more
  3 in total

Review 1.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

2.  Projecting vaccine demand and impact for emerging zoonotic pathogens.

Authors:  Anita Lerch; Quirine A Ten Bosch; Maïna L'Azou Jackson; Alison A Bettis; Mauro Bernuzzi; Georgina A V Murphy; Quan M Tran; John H Huber; Amir S Siraj; Gebbiena M Bron; Margaret Elliott; Carson S Hartlage; Sojung Koh; Kathyrn Strimbu; Magdalene Walters; T Alex Perkins; Sean M Moore
Journal:  BMC Med       Date:  2022-06-16       Impact factor: 11.150

3.  Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.

Authors:  Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2021-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.